Norway’s continued ban on nicotine pouches, in force since 2017, is one of the strictest policies in Europe. Despite mounting evidence that these products are significantly less harmful than cigarettes, they remain prohibited for sale and even private import. The intent, officials say, is to protect youth from nicotine initiation. Yet, many experts argue this approach ignores the harm reduction potential that has helped neighbouring Sweden achieve some of the lowest smoking rates in the world.
In Sweden, legal access to nicotine pouches, combined with regulated sales, has played a central role in the country’s “smoke-free” status, as defined by the World Health Organization. Public health researchers there point to clear data: making safer, smoke-free alternatives available to adult smokers accelerates the decline in cigarette use and reduces tobacco-related disease.
The Potential Harm Reduction Path
Nicotine pouches, while not risk-free, are recognised by researchers as far less harmful than combusted tobacco. Studies consistently show that switching from cigarettes to pouches drastically reduces exposure to toxicants produced by burning tobacco. Karl Erik Lund, senior researcher at the Norwegian Institute of Public Health, has long advocated for risk-proportionate regulation, policies that weigh actual product risks rather than banning safer alternatives outright. If the majority of pouch users are smokers seeking to quit cigarettes, he argues, a legal and regulated market could yield a net public health benefit.
Evidence from both Norway’s experience with snus and Sweden’s with snus and pouches reinforces this point: the overwhelming majority of users substitute these products for cigarettes, leading to measurable health gains despite a small risk of youth experimentation.
Prohibition and Its Consequences
Since the ban was enacted, Norway has denied every manufacturer’s application to sell nicotine pouches. Customs officers actively seize illicit imports, and private purchases from abroad are prohibited. Yet, surveys indicate that over one in five Norwegians still use nicotine pouches, many sourcing them from across the Swedish border. This reflects a familiar pattern seen in other countries, where prohibition fuels demand without offering a safer, regulated supply.
Critics warn that this approach criminalises adult smokers seeking to switch to lower-risk products, while doing little to address the broader harms of smoking. By treating nicotine pouches and cigarettes as equivalent, Norway risks undermining public understanding of relative risks and discouraging smokers from making life-saving changes.
Two Nordic Models, Two Outcomes
The contrast between Sweden and Norway could not be sharper. Sweden’s regulated market has driven smoking rates down to record lows, with nicotine pouches gaining mainstream acceptance among men and women alike. Norway, meanwhile, continues to maintain higher smoking prevalence, even as unregulated cross-border sales persist.
The Road Ahead
In 2025, Norway’s Directorate of Health and Ministry of Health reaffirmed their commitment to the ban, rejecting all pending applications and tightening import restrictions. Some political voices are calling for reform, but so far, no legislative changes have been made.
Norway now faces a pivotal choice: continue with a prohibitionist approach that sustains the cigarette market, or adopt a harm reduction model that follows the evidence and Sweden’s example. Allowing regulated access to nicotine pouches could be a turning point, shifting smokers toward significantly safer alternatives, improving public health outcomes, and aligning with global best practices in tobacco harm reduction.
